Enanta Pharmaceuticals Inc
ENTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001177648
No open-market purchases or sales by Enanta Pharmaceuticals Inc insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $397.2M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Enanta Pharmaceuticals Inc as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 108
- −2 vs. Q1 2025
- Shares held
- 18.4M
- −183.0K (−1.0%) vs. Q1 2025
- Total value
- $139.4M
- +$36.6M (+35.6%) vs. Q1 2025
- New holders
- 15
- 34 more added
- Sold out
- 17
- 43 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 122 | $397.2M |
| Q1 2026 | 133 | $338.1M |
| Q4 2025 | 132 | $416.1M |
| Q3 2025 | 122 | $227.1M |
| Q2 2025 | 108 | $139.4M |
| Q1 2025 | 110 | $102.8M |
| Q4 2024 | 108 | $114.5M |
| Q3 2024 | 112 | $220.0M |
| Q2 2024 | 101 | $287.0M |
| Q1 2024 | 108 | $391.4M |
| Q4 2023 | 106 | $188.4M |
| Q3 2023 | 132 | $225.0M |
| Q2 2023 | 134 | $438.4M |
| Q1 2023 | 145 | $805.3M |
| Q4 2022 | 147 | $894.5M |
| Q3 2022 | 160 | $1.02B |
| Q2 2022 | 155 | $956.3M |
| Q1 2022 | 170 | $1.40B |
| Q4 2021 | 181 | $1.40B |
| Q3 2021 | 149 | $1.10B |
| Q2 2021 | 152 | $828.7M |
| Q1 2021 | 150 | $956.7M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Enanta Pharmaceuticals Inc; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Stonepine Capital Management, LLC | 604,066 | $4.57M | 4.50% | +13,324+2.3% | Added |
| Marshall Wace, LLP | 857,412 | $6.48M | 0.01% | +6,522+0.8% | Added |
| Acadian Asset Management LLC | 867,037 | $6.55M | 0.01% | 00.0% | Unchanged |
| Millennium Management LLC | 1,458,593 | $11.0M | 0.01% | +111,661+8.3% | Added |
| BlackRock, Inc. | 1,846,905 | $14.0M | 0.00% | −171,764−8.5% | Reduced |
| Vanguard Group Inc | 1,976,672 | $14.9M | 0.00% | −30,761−1.5% | Reduced |
| Krensavage Asset Management, LLC | 2,114,444 | $16.0M | 8.46% | −2,142−0.1% | Reduced |
| Farallon Capital Management, L.L.C. | 2,122,262 | $16.0M | 0.07% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −60,160−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −27,318−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −19,941−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −16,257−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −13,921−100.0% | Sold out |
| CI Private Wealth, LLC | 0 | $0 | 0.00% | −12,874−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −10,800−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −10,347−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −9,841−100.0% | Sold out |
| Public Employees Retirement Association of Colorado | 0 | $0 | 0.00% | −4,658−100.0% | Sold out |
| Picton Mahoney Asset Management | 0 | $0 | 0.00% | −3,435−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −1,456−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −1,103−100.0% | Sold out |
| Umb Bank N A | 0 | $0 | 0.00% | −978−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −386−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −361−100.0% | Sold out |
| Private Wealth Management Group, LLC | 0 | $0 | 0.00% | −96−100.0% | Sold out |